| [1] |
AJANI J A, D’AMICO T A, BENTREM D J, et al. Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2023, 21(4): 393-422.
|
| [2] |
OBERMANNOVÁ R L, LEONG T, ESMO Guidelines Committee. ESMO clinical practice guideline interim update on the treatment of locally advanced oesophageal and oesophagogastric junction adenocarcinoma and metastatic squamous-cell carcinoma[J]. ESMO Open, 2025, 10(2): 104134.
|
| [3] |
ZHANG S Q, GUO J D, ZHANG H Y, et al. Metastasis pattern and prognosis in men with esophageal cancer patients: A SEER-based study[J]. Medicine (Baltimore), 2021, 100(25): e26496.
|
| [4] |
MURPHY C M, WANG K, WACHUKU C, et al. Metastatic gastric adenocarcinoma to the cutaneous neck and chest wall[J]. SAGE Open Med Case Rep, 2024, 12: 2050313X241231515.
|
| [5] |
CULLEN G. Esophageal cancer: a case study of a rare metastatic esophageal squamous cell carcinoma[J]. Clin J Oncol Nurs, 2020, 24(4): 352-355.
doi: 10.1188/20.CJON.352-355
pmid: 32678357
|
| [6] |
MIYATA M, SHIOZAKI H, IIHARA K, et al. Relationship between E-cadherin expression and lymph-node metastasis in human esophageal cancer[J]. Int J Oncol, 1994, 4(1): 61-65.
pmid: 21566890
|
| [7] |
WENG W H, YIN J Y, ZHANG Y, et al. Metastasis-associated protein 1 promotes tumor invasion by downregulation of E-cadherin[J]. Int J Oncol, 2014, 44(3): 812-818.
|
| [8] |
NEMOTO M, ICHIKAWA H, NAGAHASHI M, et al. Phospho-sphingosine kinase 1 expression in lymphatic spread of esophageal squamous cell carcinoma[J]. J Surg Res, 2019, 234: 123-131.
doi: S0022-4804(18)30637-1
pmid: 30527463
|
| [9] |
ZHENG S Y, ZHANG Y, GONG X Z, et al. CREB1 regulates RECQL4 to inhibit mitophagy and promote esophageal cancer metastasis[J]. J Clin Biochem Nutr, 2024, 75(2): 102-110.
doi: 10.3164/jcbn.23-118
pmid: 39345293
|
| [10] |
GERDES J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies[J]. Semin Cancer Biol, 1990, 1(3): 199-206.
pmid: 2103495
|
| [11] |
BUTERA A, AMELIO I. Deciphering the significance of p53 mutant proteins[J]. Trends Cell Biol, 2025, 35(3): 258-268.
|
| [12] |
JANIC A, ABAD E, AMELIO I. Decoding p 53 tumor suppression: a crosstalk between genomic stability and epigenetic control?[J]. Cell Death Differ, 2025, 32(1): 1-8.
|
| [13] |
GSCHNELL M, VOLBERG C, HAUSER C, et al. Cutaneous metastases: from epidemiology to therapy[J]. J Dtsch Dermatol Ges, 2024, 22(7): 974-993.
|
| [14] |
GAO Y C, ZHANG H C, TANG L, et al. Cancer nanobombs delivering artoxplatin with a polyigniter bearing hydrophobic ferrocene units upregulate PD-L1 expression and stimulate stronger anticancer immunity[J]. Adv Sci (Weinh), 2024, 11(4): e2300806.
|
), 邓瑾, 刘沛华, 张泉涌, 蔡寨(
